RM
RP Management Portfolio holdings
AUM
$139M
1-Year Return
37.98%
This Quarter Return
-22.31%
1 Year Return
-37.98%
3 Year Return
+207.23%
5 Year Return
+1,005.94%
10 Year Return
–
AUM
$139M
AUM Growth
-$88.9M
(-39%)
Cap. Flow
+$0
Cap. Flow
% of AUM
0%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
–
Closed
–
Top Buys
No buys this quarter
Top Sells
No sells this quarter
Sector Composition
| 1 | Healthcare | 100% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Biohaven
BHVN
$1.7B
| $70.6M | 50.84% |
2,936,507
| – | – |
|
2
Cytokinetics
CYTK
$5.95B
| $39.4M | 28.38% |
980,392
| – | – |
|
3
BioCryst Pharmaceuticals
BCRX
$1.74B
| $28.8M | 20.78% |
3,846,154
| – | – |
|
|
VIRX
4
DELISTED
Viracta Therapeutics, Inc. Common Stock
VIRX
| $74 | ﹤0.01% |
3,700
| – | – |
|